"Tech Prophet" Who Predicted the iPhone Now Predicts...
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before Oct 16's bombshell.
Shares Stats
| Shares Outstanding | 3,124,000,000 |
| Shares Float | 3,124,000,000 |
| Shares Short | 7,690,000 |
| Insider Holdings | 1% |
| Institution Holdings | 2.51% |
About Takeda Pharmaceutical Co ADR
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
General
| Name | Takeda Pharmaceutical Co ADR |
| Ticker | TAK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Currency | USD |
| Country | USA |
| Fiscal Year End | March |
| Full Time Employees | 47,455 |
Highlights
| Analyst Target | 17.25 |
| Market Cap | 47,172,400,000 |
| PE Ratio | 51.07 |
| PEG Ratio | 0.44 |
| EBITDA | 1,219,014,950,912 |
Financials
| Profit Margin | 3.19% |
| Operating Margin | 12.76 |
| Return on Assets | 0.02 |
| Return on Equity | 0.02 |
| Revenue | 30B |
| Earnings Per Share | 0.29 |
| Revenue Per Share | 1,419.75 |
| Gross Profit | 2,911,105,974,272 |
| Quarterly Revenue Growth | -0.08 |
Valuation
| Trailing PE | 52.07 |
| Forward PE | 14.84 |
| Price/Sales (Trailing 12 Mt.) | 0.01 |
| Price/Book (Most Recent Quarter) | 1.02 |
Dividend
Takeda Pharmaceutical Co ADR pays out a dividend of $0.67 per share, with a dividend yield of 4.46%.
TAK's last dividend payment was made to shareholders on July 7, 2025.
They pay out 242.25% of their earnings out as a dividend.
Recent Dividends
| Jul 7, 2025 | $0.34 |
| Dec 12, 2024 | $0.33 |
| Jul 8, 2024 | $0.30 |
| Dec 11, 2023 | $0.32 |
Macron Warns World Will Know By Monday If Putin 'Played' Trump Again
French President Emmanuel Macron has voiced apprehensions about Vladimir Putin potentially manipulating President Trump.
California crew arrested for hundreds of Home Depot thefts worth $10M, police say
VENTURA COUNTY, Calif. (AP) — Southern California authorities say they uncovered a criminal ring that stole $10 million in merchandise from Home Depot over several years, including 600 thefts this year alone, which the company calls the largest organized retail theft in its history.
Could You Use Some Instant Cash Upfront? - Ad
Millionaire trader Jeff Clark's #1 income strategy gives you the chance to collect instant cash payouts, as much as $100 to $1,000 upfront! The great part is you can collect these upfront cash payouts without owning a single stock.... Jeff's put all the details in a special briefing titled Infinite Income Manifesto.
Mystery surrounds $1.2 billion Army contract to build huge detention tent camp in Texas desert
WASHINGTON (AP) — When last month awarded a contract worth up to $1.2 billion to build and operate what it says will become , it didn’t turn to a large government contractor or even a firm that specializes in private prisons.
The 4 rules for cash: How to manage your money the smart way
Let’s talk about cash.
The $25M Contract Nobody Is Talking About - Ad
One deal alone covers the entire valuation of this overlooked stock. And more contracts are already stacking up in Europe and the US.
Nvidia, CrowdStrike, Snowflake, CoreWeave, Polestar Automotive: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed higher on Wednesday, with the Dow Jones Industrial Average up 0.3% at 45,565.23.
NextEra Energy Eyes A Nuclear Revival
NextEra Energy plans to bring the Duane Arnold nuclear plant back online as major tech companies seek more nuclear energy.
Scarcity Meets Momentum - Ad
With insiders and institutions holding most of the float, just 9.7M shares are truly available. New contracts could ignite moves that Wall Street can't ignore.
Trump fires Fed Governor Lisa Cook, opening new front in fight for control over central bank
WASHINGTON (AP) — President Donald Trump fired late Monday, a surprise move constituting a sharp escalation in his battle to exert greater control over what has long been considered an institution .
Marriott, Toast, KeyCorp And More On CNBC's 'Final Trades'
Marriott International, which is down around 4% year-to-date, is Jenny Van Leeuwen Harrington's final trade.
The AI Blind Spot in Banking - Ad
Banks thought AI would solve compliance. Instead, it's made the problem worse. One breakthrough platform is cutting costs in half while securing every flow.
Powerball jackpot rises to an estimated $1.3 billion after no winning ticket sold
DES MOINES, Iowa (AP) — The Powerball jackpot rose to an estimated $1.3 billion Monday night after the winning numbers failed to appear.
'Make Cracker Barrel Great Again': Donald Trump, Republican Party Weigh In On Restaurant Logo Rebrand
A logo rebrand by Cracker Barrel may divide the nation with conservatives ready to boycott the restaurant. President Trump shares his advice.
October 16 Changes the Microchip Game - and Investing - Ad
George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.
Cracker Barrel relents, says its old logo will return
Cracker Barrel said late Tuesday it's returning to its old logo after critics — including President Donald Trump — protested the company's plan to modernize.
Super Micro Computer (SMCI) Shares Are Sliding Tuesday: What's Going On?
Super Micro Computer shares are trading lower Tuesday. The stock is caught in a downdraft affecting the broader semiconductor and high-growth technology sectors.
Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad
The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.
Palantir CEO Alex Karp Once Pushed For 'Department Of Offense' — Now Trump Rebrands Pentagon To 'War' Office As PLTR Touts America's AI Edge
President Donald Trump rebranded the Pentagon as the "Department of War" on Friday, echoing Palantir CEO Alex Karp's earlier call for a more offensive U.S. military strategy as AI becomes central to global power competition.
5 Regional Bank Stocks Exploding Higher
Regional banks MBCN, PVBC, UBCP, NKSH, and FVCB surge in quality rankings, signaling strong financial health. Explore opportunities.
Is This Elon's Worst Nightmare? - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
A downturn in international travel to the U.S. may last beyond summer, experts warn
LAS VEGAS (AP) — For a few hopeful weeks this summer, a bright billboard on the major highway linking Toronto to New York greeted Canadian drivers with a simple message: "Buffalo Loves Canada.”
Why Quantum Computing (QUBT) Stock Is Getting Crushed Today
Shares of Quantum Computing are caught in a broader market selloff Tuesday. Rising U.S. Treasury yields spook investors away from growth sectors.
The Roadmap to $100M+ Revenue - Ad
Recurring deals, Tier-1 banks, and expansion into new markets put this company on track to triple revenue by 2026. Yet the market cap is still just $21M.
OpenAI and Meta say they're fixing AI chatbots to better respond to teens in distress
SAN FRANCISCO (AP) — Artificial intelligence chatbot makers OpenAI and Meta say they are adjusting how their chatbots respond to teenagers and other users asking questions about suicide or showing signs of mental and emotional distress.
Marjorie Taylor Greene Put Money In BlackRock's Bitcoin ETF This Year — Here's How Her Returns Stack Up Against Others In Congress
Rep. Marjorie Taylor Greene (R-Ga.) has added considerable Bitcoin (CRYPTO: BTC) exposure to her investment portfolio in 2025, making strategic purchases into iShares Bitcoin Trust ETF (NASDAQ:IBIT).
The Next Palantir Moment Could Be Here - Ad
A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.
Jim Cramer Expects Palantir To Reach New All-Time High
Market analysts and financial commentators provide crucial guidance in the volatile investment landscape. Cramer says no to VKTX, but expects PLTR to go up.
China protests Taiwan foreign minister's visit to the Philippines
MANILA, Philippines (AP) — Taiwan’s foreign minister has flown to the Philippines as head of a high-level delegation of investors, two senior Philippine officials said Saturday, prompting a protest from China and a warning to Manila “not to play with fire.”
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before Oct 16's bombshell.
Elon Musk's Legal Team Fights To Block OpenAI's Access To Meta's Bid Documents
Elon Musk's legal team has filed a motion to prevent OpenAI from obtaining documents related to a previous $97.4 billion bid for its assets, according to a court filings.
HP Q3 FY2025 Earnings Call Transcript
Here is the transcript from HP Q3 FY2025 earnings call.
Could You Use Some Instant Cash Upfront? - Ad
Millionaire trader Jeff Clark's #1 income strategy gives you the chance to collect instant cash payouts, as much as $100 to $1,000 upfront! The great part is you can collect these upfront cash payouts without owning a single stock.... Jeff's put all the details in a special briefing titled Infinite Income Manifesto.
A Chinese mining company is accused of covering up the extent of a major toxic spill in Zambia
LUSAKA, Zambia (AP) — A Chinese-owned mining company has been accused of covering up the extent of that polluted a major river that millions rely on with cyanide and arsenic.
Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data
Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound risk.
The $25M Contract Nobody Is Talking About - Ad
One deal alone covers the entire valuation of this overlooked stock. And more contracts are already stacking up in Europe and the US.
Tariff Impact Exposes Aluminum Market Fragility
US and EU face challenges in aluminum supply chain due to Trump's tariff policy. EU prepares emergency measures to protect industry.
Don't look now, but there's an AI-generated Italian teacup on your child's phone. What does it mean?
In the first half of 2025, she racked up over 55 million views on TikTok and 4 million likes, mostly from tweens glued to their cellphones. Not bad for an AI-generated cartoon ballerina with a cappuccino teacup for a head.
Scarcity Meets Momentum - Ad
With insiders and institutions holding most of the float, just 9.7M shares are truly available. New contracts could ignite moves that Wall Street can't ignore.
Salesforce, Rocket Lab, American Eagle, Gitlab And Figma: Why These 5 Stocks Are On Investors' Radars Today
CRM, RKLB, AEO, GTLB, FIG were among the stocks seen trending among investors on Wednesday, Sep. 3, 2025.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.